Data Sheet
HMO Series
Recombinant Yeast Fermentation | ≥98% Target Purity
Quality Summary
By utilizing a robust yeast platform, our HMO production eliminates the risk of endotoxin impurities associated with legacy E.coli methods. This ensures a cleaner baseline for downstream formulation. We are capable of supplying stable, multi-ton batches to global formula manufacturers.
Available Specifications
2'-FL (2'-Fucosyllactose)
Standardized high-purity powder
LNnT (Lacto-N-neotetraose)
High uniformity
LNT (Lacto-N-tetraose)
Stringent microbial limits
3-FL (3-Fucosyllactose)
Batch documentation and technical review support available
Contact Sales
Send specs and volume estimates—our team will reply with next steps and technical coordination.
Contact Sales